Annual Accounts Receivable
$557.70 M
+$54.46 M+10.82%
December 31, 2024
Summary
- As of March 10, 2025, GMED annual accounts receivable is $557.70 million, with the most recent change of +$54.46 million (+10.82%) on December 31, 2024.
- During the last 3 years, GMED annual accounts receivable has risen by +$393.26 million (+239.16%).
- GMED annual accounts receivable is now at all-time high.
Performance
GMED Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$557.70 M
-$30.35 M-5.16%
December 31, 2024
Summary
- As of March 10, 2025, GMED quarterly accounts receivable is $557.70 million, with the most recent change of -$30.35 million (-5.16%) on December 31, 2024.
- Over the past year, GMED quarterly accounts receivable has stayed the same.
- GMED quarterly accounts receivable is now -8.84% below its all-time high of $611.78 million, reached on June 30, 2024.
Performance
GMED Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
GMED Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.8% | 0.0% |
| 3 y3 years | +239.2% | +12.9% |
| 5 y5 years | +261.4% | +12.9% |
GMED Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +239.2% | -8.8% | +239.2% |
| 5 y | 5-year | at high | +293.6% | -8.8% | +322.2% |
| alltime | all time | at high | +1214.3% | -8.8% | +1093.5% |
Globus Medical Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $557.70 M(+10.8%) | $557.70 M(-5.2%) |
| Sep 2024 | - | $588.05 M(-3.9%) |
| Jun 2024 | - | $611.78 M(+14.5%) |
| Mar 2024 | - | $534.33 M(+6.2%) |
| Dec 2023 | $503.24 M(+136.0%) | $503.24 M(+1.8%) |
| Sep 2023 | - | $494.11 M(+105.7%) |
| Jun 2023 | - | $240.18 M(+7.8%) |
| Mar 2023 | - | $222.78 M(+4.5%) |
| Dec 2022 | $213.25 M(+29.7%) | $213.25 M(+3.4%) |
| Sep 2022 | - | $206.31 M(+7.0%) |
| Jun 2022 | - | $192.81 M(+16.0%) |
| Mar 2022 | - | $166.22 M(+1.1%) |
| Dec 2021 | $164.44 M(+16.1%) | $164.44 M(+3.0%) |
| Sep 2021 | - | $159.58 M(-3.8%) |
| Jun 2021 | - | $165.85 M(+3.1%) |
| Mar 2021 | - | $160.94 M(+13.6%) |
| Dec 2020 | $141.68 M(-8.2%) | $141.68 M(-1.1%) |
| Sep 2020 | - | $143.27 M(+8.5%) |
| Jun 2020 | - | $132.09 M(-4.7%) |
| Mar 2020 | - | $138.60 M(-10.2%) |
| Dec 2019 | $154.33 M(+12.6%) | $154.33 M(+9.0%) |
| Sep 2019 | - | $141.54 M(-2.2%) |
| Jun 2019 | - | $144.68 M(+3.6%) |
| Mar 2019 | - | $139.62 M(+1.9%) |
| Dec 2018 | $137.07 M | $137.07 M(+15.3%) |
| Sep 2018 | - | $118.85 M(+0.2%) |
| Jun 2018 | - | $118.56 M(-3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $122.58 M(+5.1%) |
| Dec 2017 | $116.68 M(+26.8%) | $116.68 M(+23.5%) |
| Sep 2017 | - | $94.48 M(-1.1%) |
| Jun 2017 | - | $95.49 M(+1.3%) |
| Mar 2017 | - | $94.23 M(+2.4%) |
| Dec 2016 | $91.98 M(+18.4%) | $91.98 M(+6.1%) |
| Sep 2016 | - | $86.71 M(+16.1%) |
| Jun 2016 | - | $74.71 M(-1.1%) |
| Mar 2016 | - | $75.53 M(-2.8%) |
| Dec 2015 | $77.68 M(+3.0%) | $77.68 M(+0.1%) |
| Sep 2015 | - | $77.60 M(+6.2%) |
| Jun 2015 | - | $73.05 M(-0.2%) |
| Mar 2015 | - | $73.17 M(-3.0%) |
| Dec 2014 | $75.43 M(+20.9%) | $75.43 M(+20.5%) |
| Sep 2014 | - | $62.60 M(-3.8%) |
| Jun 2014 | - | $65.05 M(+2.9%) |
| Mar 2014 | - | $63.22 M(+1.3%) |
| Dec 2013 | $62.41 M(+16.7%) | $62.41 M(+12.9%) |
| Sep 2013 | - | $55.27 M(-3.9%) |
| Jun 2013 | - | $57.53 M(-3.2%) |
| Mar 2013 | - | $59.42 M(+11.1%) |
| Dec 2012 | $53.50 M(+14.5%) | $53.50 M(+3.1%) |
| Sep 2012 | - | $51.86 M(+4.8%) |
| Jun 2012 | - | $49.48 M(-2.7%) |
| Mar 2012 | - | $50.83 M(+8.8%) |
| Dec 2011 | $46.73 M(+10.1%) | $46.73 M |
| Dec 2010 | $42.43 M | - |
FAQ
- What is Globus Medical annual accounts receivable?
- What is the all time high annual accounts receivable for Globus Medical?
- What is Globus Medical annual accounts receivable year-on-year change?
- What is Globus Medical quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Globus Medical?
- What is Globus Medical quarterly accounts receivable year-on-year change?
What is Globus Medical annual accounts receivable?
The current annual accounts receivable of GMED is $557.70 M
What is the all time high annual accounts receivable for Globus Medical?
Globus Medical all-time high annual accounts receivable is $557.70 M
What is Globus Medical annual accounts receivable year-on-year change?
Over the past year, GMED annual accounts receivable has changed by +$54.46 M (+10.82%)
What is Globus Medical quarterly accounts receivable?
The current quarterly accounts receivable of GMED is $557.70 M
What is the all time high quarterly accounts receivable for Globus Medical?
Globus Medical all-time high quarterly accounts receivable is $611.78 M
What is Globus Medical quarterly accounts receivable year-on-year change?
Over the past year, GMED quarterly accounts receivable has changed by $0.00 (0.00%)